Human papillomavirus DNA methylation as a potential biomarker for cervical cancer.
about
Cancer diagnostic classifiers based on quantitative DNA methylationMolecular mechanisms of HPV mediated neoplastic progressionDeep sequencing of HPV16 genomes: A new high-throughput tool for exploring the carcinogenicity and natural history of HPV16 infection.Increased methylation of human papillomavirus type 16 DNA is associated with the severity of cervical lesions in infected females from northeast China.Characterization of HPV DNA methylation of contiguous CpG sites by bisulfite treatment and massively parallel sequencing-the FRAGMENT approach.Methylation of human papillomavirus 16, 18, 31, and 45 L2 and L1 genes and the cellular DAPK gene: Considerations for use as biomarkers of the progression of cervical neoplasia.Human Papillomavirus 16, 18, 31 and 45 viral load, integration and methylation status stratified by cervical disease stage.Differential methylation of genes associated with cell adhesion in preeclamptic placentas.Reduced expression of autophagy markers correlates with high-risk human papillomavirus infection in human cervical squamous cell carcinomaHPV16 methyl-haplotypes determined by a novel next-generation sequencing method are associated with cervical precancerPromoter hypermethylation of KLF4 inactivates its tumor suppressor function in cervical carcinogenesis.Human papillomavirus genomics: past, present and futureMethylated Host Cell Gene Promoters and Human Papillomavirus Type 16 and 18 Predicting Cervical Lesions and Cancer.RNA Binding Proteins that Control Human Papillomavirus Gene Expression.HPVbase--a knowledgebase of viral integrations, methylation patterns and microRNAs aberrant expression: As potential biomarkers for Human papillomaviruses mediated carcinomasCpG Methylation Analysis of HPV16 in Laser Capture Microdissected Archival Tissue and Whole Tissue Sections from High Grade Anal Squamous Intraepithelial Lesions: A Potential Disease Biomarker.Curcumin Nanoformulation for Cervical Cancer Treatment.Triage of HPV positive women in cervical cancer screening.HPV-based Tests for Cervical Cancer Screening and Management of Cervical Disease.HPV16 CpG methyl-haplotypes are associated with cervix precancer and cancer in the Guanacaste natural history study.Identification of key genes associated with cervical cancer by comprehensive analysis of transcriptome microarray and methylation microarray.Human papillomavirus infection and the multistage carcinogenesis of cervical cancer.Methylation of human papillomavirus Type 16 CpG sites at E2-binding site 1 (E2BS1), E2BS2, and the Sp1-binding site in cervical cancer samples as determined by high-resolution melting analysis-PCR.Epigenetics of human papillomaviruses.Cervical neoplasia-related factors and decreased prevalence of uterine fibroids among a cohort of African American women.DNA Methylation Status of PAX1 and ZNF582 in Esophageal Squamous Cell CarcinomaUnderstanding HPV tests and their appropriate applications.Natural history of high-grade cervical intraepithelial neoplasia: a review of prognostic biomarkers.Epigenetic Alterations in Human Papillomavirus-Associated Cancers.Cervical cancer: A comprehensive approach towards extermination.Highly sensitive detection of DNA methylation levels by using a quantum dot-based FRET method.Management of high-risk HPV-positive women for detection of cervical (pre)cancer.Splicing and Polyadenylation of Human Papillomavirus Type 16 mRNAs.Methylation-specific digital karyotyping of HPV16E6E7-expressing human keratinocytes identifies novel methylation events in cervical carcinogenesis.Molecular tests potentially improving HPV screening and genotyping for cervical cancer prevention.Mycoplasma hominis and Mycoplasma genitalium in the Vaginal Microbiota and Persistent High-Risk Human Papillomavirus Infection.Discovery and validation of candidate host DNA methylation markers for detection of cervical precancer and cancer.Quantitative Measurement of L1 Human Papillomavirus Type 16 Methylation for the Prediction of Preinvasive and Invasive Cervical Disease.5-aza-2'-deoxycytidine (DAC) treatment downregulates the HPV E6 and E7 oncogene expression and blocks neoplastic growth of HPV-associated cancer cells.CADM1 and MAL methylation status in cervical scrapes is representative of the most severe underlying lesion in women with multiple cervical biopsies.
P2860
Q27012960-E9BDCBA9-0E3B-488A-9D9B-6ED75830C991Q28070323-E84E5DC6-A15E-44D0-99F7-FAB528941723Q30685686-67AF9C59-3C0F-4306-B714-28F45745322AQ33684676-48CEE684-10B1-4588-B5EA-5A7E6BAACF56Q33703182-D2FC2795-3EFE-4628-B715-9F730B9BC61AQ33733302-B24ABD51-AEF7-4DD9-BA01-3CBC7B2F119DQ33740118-AE6ACA3D-A9AE-405D-AA6A-ED42C14C62C1Q33806626-ECD2B8EA-EFF3-4E60-A2A9-D98294CD131EQ34141721-C23AD355-9DE7-4738-9E6B-1FEBED37BB03Q34675069-5BB9E018-2D4B-405B-97F4-DAAC9CADFA5DQ35097588-609B07AE-E0C3-461B-8AA9-9EFE82B2C8A6Q35604116-5AAB1ABE-B1C7-4704-82FE-4CE8CC0ABD89Q35658044-DA76D168-BA12-40FC-87BF-81829858190DQ35834013-6E4E6611-DC4C-4870-B848-3853A47535AFQ35884544-E94F3DEA-EA28-4D70-A2B1-9A3B1A02EBF0Q36104985-E3C2FEA5-58FF-401A-8B1C-27C5A59628DAQ36536202-822779CF-94EA-47F8-968D-CFAD50EDFFD6Q36679896-CB1FFDD9-882E-4E51-AA26-753B36A78A12Q36856284-7D66242F-E21D-464F-861B-A60D93BF3A72Q36901882-DE1E1DDC-DEAD-48C6-BF4A-47A8B8148246Q37002191-63C9944E-F3EB-460C-8BB5-4B04E31B684AQ37013482-C1703C0F-E5D2-43A5-87DA-E1FE9BAC3BC1Q37264251-C685EF78-13EA-40E1-B0D6-11111D2292D0Q37293605-AA4669B4-5995-43CE-9854-76BFD8D97444Q37431867-48F721D8-9B5A-4D66-89CF-BE57EA3CA8F7Q37678573-A5F3BEF8-3E36-4198-B490-C6FCAC1E2365Q38133612-C164AA30-3DC7-43F7-B9D2-49862BAE9E4DQ38363737-4066E8A5-BE28-4BFB-BC7A-BA9D2CE95920Q38598051-6C7786EE-C79B-43C1-B953-5294FA1407A6Q38748682-5598149C-4ACA-4AB0-87AB-5850ABE31ED3Q38829611-1C4E77EE-1D1B-497B-8BD3-E80A0974AFA2Q38837737-A5785779-38FF-4EEF-AFCF-A5B22247F1C4Q39139279-6A7BC21E-1EAD-498F-87E9-9A3601B81844Q39151945-7ECEAC2A-5358-4860-9E80-E51181C1AC14Q39170424-E914990A-BD95-4790-859E-F71FB4A95478Q40128101-BE73F0F3-21C3-48A8-B805-7ADDEEB5F0AAQ40202976-15621F23-B626-4409-BBCD-B9929326E31CQ40341777-E1D4D64B-1B33-4203-A2E7-D5AB76465374Q40651597-60EB995C-D965-48F4-BC23-EA212AEF4C44Q41538167-80C73A97-D986-45ED-8D40-6606D8AE69AE
P2860
Human papillomavirus DNA methylation as a potential biomarker for cervical cancer.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
Human papillomavirus DNA methylation as a potential biomarker for cervical cancer.
@en
type
label
Human papillomavirus DNA methylation as a potential biomarker for cervical cancer.
@en
prefLabel
Human papillomavirus DNA methylation as a potential biomarker for cervical cancer.
@en
P2093
P2860
P50
P1476
Human papillomavirus DNA methylation as a potential biomarker for cervical cancer.
@en
P2093
Ariana Harari
Arpita Ghosh
Attila Lorincz
Lisa Mirabello
Megan A Clarke
Robert D Burk
P2860
P304
P356
10.1158/1055-9965.EPI-12-0905
P577
2012-10-03T00:00:00Z